DFN-02 Nasal Spray (Sumatriptan 10 Mg + Permeation Enhancer) in the Acute Treatment of Migraine: better Sustained Pain Freedom and Total Migraine Freedom with Lower Rescue Medication Use Compared with Placebo

Munjal S.; Brand-Schieber E.

首页> 外文期刊>Headache >DFN-02 Nasal Spray (Sumatriptan 10 Mg + Permeation Enhancer) in the Acute Treatment of Migraine: better Sustained Pain Freedom and Total Migraine Freedom with Lower Rescue Medication Use Compared with Placebo

【24h】

DFN-02 Nasal Spray (Sumatriptan 10 Mg + Permeation Enhancer) in the Acute Treatment of Migraine: better Sustained Pain Freedom and Total Migraine Freedom with Lower Rescue Medication Use Compared with Placebo

机译：DFN-02鼻腔喷雾（Sumatriptan 10mg +渗透增强剂）在偏头痛的急性治疗中：与安慰剂相比，使用较低的救援药物治疗较好的疼痛自由和总偏头痛自由度

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Headache》 |2018年第8期|共2页
作者
Munjal S.; Brand-Schieber E.;
展开▼
作者单位

Promius Pharma Princeton NJ USA;

Promius Pharma Princeton NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词

相似文献

外文文献
中文文献

1. DFN-02 Nasal Spray (Sumatriptan 10 Mg + Permeation Enhancer) in the Acute Treatment of Migraine: better Sustained Pain Freedom and Total Migraine Freedom with Lower Rescue Medication Use Compared with Placebo [J] . Munjal S., Brand-Schieber E. Headache . 2018,第8期

机译：DFN-02鼻腔喷雾（Sumatriptan 10mg +渗透增强剂）在偏头痛的急性治疗中：与安慰剂相比，使用较低的救援药物治疗较好的疼痛自由和总偏头痛自由度
2. DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind, Placebo‐Controlled Study [J] . Lipton Richard B., Munjal Sagar, Brand‐Schieber Elimor, Headache . 2018,第5期

机译：DFN-02（Sumatriptan 10mg渗透增强剂）鼻腔喷雾VS安慰剂在偏头痛的急性治疗中：双盲，安慰剂对照研究
3. DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind, Placebo‐Controlled Study [J] . Lipton Richard B., Munjal Sagar, Brand‐Schieber Elimor, Headache . 2018,第Suppla2期

机译：DFN-02（Sumatriptan 10mg渗透增强剂）鼻腔喷雾VS安慰剂在偏头痛的急性治疗中：双盲，安慰剂对照研究
4. DFN-02 Sumatriptan 10 mg Nasal Spray with Permeation Enhancer for the Acute Treatment of Migraine: A Randomized Double-Blind Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment [O] . Richard B. Lipton, Sagar Munjal, Elimor Brand-Schieber, -1

机译：DFN-02舒马曲坦10毫克鼻腔喷雾剂和渗透促进剂用于偏头痛的急性治疗：一项随机双盲安慰剂对照的研究评估功能障碍和受试者对治疗的满意度
5. DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment [O] . Richard B. Lipton, Sagar Munjal, Elimor Brand-Schieber, 2019

机译：DFN-02，Sumatriptan 10mg鼻腔喷雾渗透增强剂，用于偏头痛的急性治疗：随机，双盲，安慰剂对照研究评估功能性残疾和治疗的主题满足

DFN-02 Nasal Spray (Sumatriptan 10 Mg + Permeation Enhancer) in the Acute Treatment of Migraine: better Sustained Pain Freedom and Total Migraine Freedom with Lower Rescue Medication Use Compared with Placebo

著录项

相似文献

相关主题

期刊订阅